Pregnancy medicines shortage sparks concern The RACGP has joined RANZCOG to address nationwide supply issues related to a lack of clinical trials and off-patent drugs.
Preventive care for atrial fibrillation currently ‘less than ideal’ More than four-in-10 patients hospitalised with the condition die within a decade, according to a new Australian study.
Sydney home raided after Ozempic scam The TGA is urging GPs ‘exercise deep caution’ after doctors were faxed ads promoting allegedly illegally compounded semaglutide.
‘Absolutely tiny’ Federal obesity funding challenged Questions have been raised about why no weight loss drugs are on the PBS, as research highlights the lack of funding for obesity prevention.
Can medicine repurposing help GPs? Quality care experts say GPs should consider a new TGA program looking to expand prescribing criteria and medicine access, but there are caveats.
Antidepressant withdrawal: The hidden danger New benchmark guidelines highlight the dangers of antidepressant withdrawal and support GPs in safe deprescribing.
New GP resource aims to help asthma patients’ sleep The document advises doctors not to ‘accept nocturnal asthma symptoms as normal’, offering instruction for treating sleep disturbances.
In Practice: Updates to allied health MBS items Referral changes to MBS items for Aboriginal and Torres Strait Islander patients accessing allied health services are now in place.
In Practice: Self-care for GPs An upcoming webinar will discuss self-care strategies and explore the evidence-based benefits and nuances of mindfulness.
In Practice: Defect alert for insulin brands The TGA has issued an urgent product defect alert for glass cartridge insulin products on behalf of the manufacturer, Novo Nordisk.